Placebo Current Events | Placebo News | 10
|
| Page
10 of
26 |
519 Results |
|
|
|
Sort By:
Page Views | Date |
New evidence for homeopathy
Two new studies conclude that a review which claimed that homeopathy is just a placebo, published in The Lancet, was seriously flawed. view more (2008-11-04)
ESC Congress 2003: New oral anticoagulant shows promise to reduce major cardiovascular events following heart attacks
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Hot Line II - Acute coronary syndromes / percutaneous coronary... view more... (2003-09-01)
Trial raises doubts over alternative pain therapy for arthritis
Copper bracelets and magnetic wrist straps are ineffective in relieving arthritis pain, according to a new study led by a University of York academic. view more (2009-10-16)
DRUG MAY HELP REDUCE SEVERE CONSEQUENCES OF MENINGOCOCCAL SEPSIS (pp 954, 961)
A modified version of a protein found within white blood cells could help to decrease the severe complications of meningococcal sepsis, according to the results of a trial published in this week's issue of THE LANCET. The bacterium Neisseria meningitidis (also known as the meningococcus) causes meningitis, but can also result in sepsis-a... view more... (2000-09-14)
Anaemia Treatment Could Worsen Cancer Prognosis (p1255)
Results of a European study in this week's issue of THE LANCET cast doubt over the value of treating anaemia with erythropoietin (epoetin beta) among patients who have cancer. Results of the study show that anaemic patients fare better in terms of reduced cancer progression and increased survival if their anaemia is not treated around the time of... view more... (2003-10-15)
Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis view more (2006-04-12)
Supplementary approach to malaria
Could a simple vitamin A and zinc supplement help protect young children from malaria" A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes. view more (2008-02-06)
Remicade therapy shown to improve productivity in patients treated for chronic plaque psoriasis
Investigators reported today at the American Academy of Dermatology annual meeting that patients with moderate to severe plaque psoriasis receiving REMICADE® (infliximab) induction and maintenance therapy experienced significant improvements in productivity at week 10, which were sustained through week 50. view more (2007-02-05)
X-CELLENT News For BP Management
New trial findings, presented at last week's European Society of Hypertension meeting in Paris, have provided a clearer perspective on optimum treatment of patients with isolated systolic hypertension (ISH). Results from the X-CELLENT study showed that the thiazide-like diuretic indapamide SR offers benefits over both the calcium channel blocker... view more... (2004-06-25)
Pharmaceutical study: Less hemorrhaging after stroke, but not fewer deaths
An international study published in May 2008 in the "New England Journal of Medicine" has shown that the coagulation factor VIIa can limit the extent of a cerebral hemorrhage. However, in the long term it does not prevent death or severe impairment. view more (2008-06-12)
Phase IIb data show that BG-12 significantly reduced brain lesions in multiple sclerosis
Biogen Idec (NASDAQ: BIIB) today announced the publication of Phase IIb data showing that a 240 mg three-times-daily dose of the company's novel oral compound, BG-12 (BG00012, dimethyl fumarate), reduced the number of new gadolinium enhancing (Gd+) lesions by 69 percent in patients with relapsing-remitting multiple sclerosis (MS) when compared to... view more... (2008-10-24)
Epilepsy drug may help alcoholics recover from dependence, small study suggests
It's a Catch-22 of the highest order. People with alcohol problems often use alcohol to get to sleep -- but it actually keeps them from getting good-quality sleep all night long. view more (2008-08-04)
Supplements no better than placebo in slowing cartilage loss in knees of osteoarthritis patients
In a two-year multicenter study led by University of Utah doctors, the dietary supplements glucosamine and chondroitin sulfate performed no better than placebo in slowing the rate of cartilage loss in the knees of osteoarthritis patients. view more (2008-09-30)
Commonly recommended sedative does not improve infant sleep
An antihistamine often recommended to parents whose infants do not sleep through the night may not be effective in reducing nighttime awakenings or improving parents' happiness with their children's sleep. view more (2006-07-05)
Efficacy of glucosamine, chondroitin sulfate may depend on level of osteoarthritis pain
The popular dietary supplements glucosamine and chondroitin sulfate proved no better than a placebo in relieving osteoarthritis knee pain in most participants of a major national trial. view more (2006-02-23)
ADDERALL XR significantly improves driving performance, attention in young adults with ADHD
ADDERALL XR® (mixed salts of a single-entity amphetamine product) significantly improved driving performance, cognitive function and attention in young adults with attention-deficit/hyperactivity disorder (ADHD). view more (2005-11-09)
Promising treatment for post-traumatic stress disorder sleep disturbances
For sufferers of Post Traumatic Stress Disorder (PTSD), sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide. view more (2007-04-19)
Study of drug therapy for compulsive buying yields a puzzle, Stanford researcher says
Researchers at the Stanford University School of Medicine say they are puzzled by findings from their new study indicating that an antidepressant, which previously showed promise in treating a behavioral disorder known as compulsive buying, did not result in a sustained benefit for the patients who took it. view more (2007-03-14)
Zinc supplements could help treat ADHD
As attention deficit hyperactivity disorder (ADHD) affects around 1 in every 25 school-aged children, managing this condition is of huge social importance. An article published in BMC Psychiatry this week shows that zinc supplements could increase the effectiveness of stimulants used to treat children with the disease. The effects of ADHD on... view more... (2004-04-06)
New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. view more (2008-07-24)
|
|
| Page
10 of
26 |
519 Results |
|
|
|
Sort By:
Page Views | Date |
|
